Pharma channel feed – Endpoints News

Pharma channel feed

Pfizer, J&J, Novo, Lilly and Sanofi among pharma TV ads jamming at Grammy music awards

4 years ago

FDA tees up a snap review for Dupixent as Sanofi, Regeneron hunt 4th approval for megablockbuster

4 years ago

Alnylam's potential fourth RNAi approval delayed three months, but impact likely to be 'modest'

4 years ago

'Rapid' path for Curis' lead leukemia drug hits roadblock with partial clinical hold after patient death

4 years ago

Sanofi taps outsiders for new board to check its homework on diversity, equity and inclusion

4 years ago

Cross-cultural study finds health tech and advertising popular with Hispanic community, amid generational shifts

4 years ago

Novartis CEO Vas Narasimhan restructures the pharma giant, cutting costs $1B+, ousting top execs and signaling layoffs ahead

4 years ago

Sage touts positive early signals in Alzheimer's. Will they be able to repeat it in a blinded study?

4 years ago

Middle of the road for CEOs: Bristol Myers' Giovanni Caforio secured almost $20M in 2021 compensation

4 years ago

Ontario antes up $580M for C&G therapy plant in Hamilton

4 years ago

In Lilly social media video series, employees open up about Alzheimer's personal ties — and inspiration

4 years ago

Seagen CEO Clay Siegall hauls in more than most European counterparts and Moderna's Bancel

4 years ago

Sanofi's plan to list its API spinout in France is a go

4 years ago

Most Chinese firms could keep their US listings under draft framework — report

4 years ago

House passes $35 monthly insulin caps, but Senate remains a question mark

4 years ago

Rick Gonzalez stays in the winners circle at AbbVie, grabbing $24M comp package

4 years ago

Biohaven’s top scientist stars in new ‘Ideahaven’ migraine campaign, adding to its marketing bag of tricks

4 years ago

Clovis Oncology heralds a PARP victory in frontline ovarian cancer — does anyone really care much?

4 years ago

Florida becomes next state to seal big opioid settlement deal, bagging $878M from Teva, Allergan and others

4 years ago

Pear Therapeutics sets the stage for a fruitful 2022, forecasting a five-fold boost in revenue

4 years ago

On a mission to reshape Sanofi, Paul Hudson takes a slight pay cut

4 years ago

Updated: SEC chair denies a deal to prevent Chinese company delisting is close — reports

4 years ago

From public relations into broader marketing, GMHC rebrands to reflect agency network evolution

4 years ago

$35 monthly insulin cap: Republicans decry how White House, Dems plan to pay for it

4 years ago

First page Previous page 211 212 213214215 216 217 Next page Last page